PhRMA Promotes Cluster Concept In Japan Reform Wish List

Holistic Changes Needed, US Group Says

US industry association promotes an exchanges with Japan on bioclusters, while continuing to push for holistic debate on reforms to the country’s national healthcare system and changes to reimbursement pricing it sees as supporting innovation.

wish list of policy change for pharma has become longer recently
US innovator group lists Japan reform items • Source: Shutterstock

The US research-based industry group The Pharmaceutical and Research Manufacturers of America (PhRMA) is continuing to advocate for broad debate around reforms to Japan’s healthcare and drug reimbursement pricing systems, as it seeks to create an environment it sees as conducive to sustainable innovation, patient access to new drugs and economic benefits.

While many of the themes are familiar, one particular emphasis this year was a healthcare innovation roundtable, under which the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Japan

More from Asia